Pharming Group NV (PHAR)
10.55
-0.27
(-2.50%)
USD |
NASDAQ |
Sep 15, 16:00
10.46
-0.09
(-0.85%)
Pre-Market: 20:00
Pharming Group Price to Book Value : 2.905 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 2.905 |
| September 14, 2026 | 2.980 |
| September 11, 2026 | 3.087 |
| September 10, 2026 | 2.975 |
| September 09, 2026 | 3.021 |
| September 08, 2026 | 3.167 |
| September 04, 2026 | 3.092 |
| September 03, 2026 | 3.156 |
| September 02, 2026 | 3.084 |
| September 01, 2026 | 3.059 |
| August 31, 2026 | 3.161 |
| August 28, 2026 | 3.222 |
| August 27, 2026 | 3.244 |
| August 26, 2026 | 3.291 |
| August 25, 2026 | 3.241 |
| August 24, 2026 | 3.156 |
| August 21, 2026 | 3.263 |
| August 20, 2026 | 3.216 |
| August 19, 2026 | 3.263 |
| August 18, 2026 | 3.280 |
| August 17, 2026 | 3.247 |
| August 14, 2026 | 3.227 |
| August 13, 2026 | 3.401 |
| August 12, 2026 | 3.258 |
| August 11, 2026 | 3.368 |
| Date | Value |
|---|---|
| August 10, 2026 | 3.125 |
| August 07, 2026 | 3.015 |
| August 06, 2026 | 2.988 |
| August 05, 2026 | 2.940 |
| August 04, 2026 | 2.825 |
| August 03, 2026 | 2.704 |
| July 31, 2026 | 2.776 |
| July 30, 2026 | 2.960 |
| July 29, 2026 | 3.307 |
| July 28, 2026 | 3.541 |
| July 27, 2026 | 3.583 |
| July 24, 2026 | 3.474 |
| July 23, 2026 | 3.627 |
| July 22, 2026 | 3.569 |
| July 21, 2026 | 3.614 |
| July 20, 2026 | 3.610 |
| July 17, 2026 | 3.709 |
| July 16, 2026 | 3.660 |
| July 15, 2026 | 3.690 |
| July 14, 2026 | 3.694 |
| July 13, 2026 | 3.792 |
| July 10, 2026 | 3.817 |
| July 09, 2026 | 3.866 |
| July 08, 2026 | 3.938 |
| July 07, 2026 | 3.982 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ProQR Therapeutics NV | 2.858 |
| NewAmsterdam Pharma Co. NV | 3.943 |
| argenx SE | -- |
| DBV Technologies SA | 3.348 |
| ACADIA Pharmaceuticals, Inc. | 3.525 |
Price to Book Value Related Metrics
| PE Ratio | 84.88 |
| PS Ratio | 2.121 |
| Price to Free Cash Flow | 30.22 |
| Price | 10.55 |
| Earnings Yield | 1.18% |
| Market Cap | 746.71M |
| Operating PE Ratio | 34.75 |
| Normalized PE Ratio | 47.35 |